Cognition Therapeutics, Inc.2024财年第二财季实现净利润-7.04百万美元，同比减少48.84%

自选股智能写手08-18

8月18日，Cognition Therapeutics, Inc.（CGTX.US）公布财报，公告显示公司2024财年第二财季净利润为-7.04百万美元，同比减少48.84%；其中营业收入为0.00美元，每股基本收益为-0.18美元。从资产负债表来看，Cognition Therapeutics, Inc.（CGTX.US）总负债11.36百万美元，其中短期债务184000.00美元，资产负债...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2460736374?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-18 00:03","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2460736374","market":"us","top_or_hot":-1,"title":"Cognition Therapeutics, Inc.2024财年第二财季实现净利润-7.04百万美元，同比减少48.84%","media":"自选股智能写手","content":"<div>\n<p>8月18日，Cognition Therapeutics, Inc.（CGTX.US）公布财报，公告显示公司2024财年第二财季净利润为-7.04百万美元，同比减少48.84%；其中营业收入为0.00美元，每股基本收益为-0.18美元。从资产负债表来看，Cognition Therapeutics, Inc.（CGTX.US）总负债11.36百万美元，其中短期债务184000.00美元，资产负债...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800061095a1675b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cognition Therapeutics, Inc.2024财年第二财季实现净利润-7.04百万美元，同比减少48.84%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCognition Therapeutics, Inc.2024财年第二财季实现净利润-7.04百万美元，同比减少48.84%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-18 00:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800061095a1675b&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月18日，Cognition Therapeutics, Inc.（CGTX.US）公布财报，公告显示公司2024财年第二财季净利润为-7.04百万美元，同比减少48.84%；其中营业收入为0.00美元，每股基本收益为-0.18美元。从资产负债表来看，Cognition Therapeutics, Inc.（CGTX.US）总负债11.36百万美元，其中短期债务184000.00美元，资产负债...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800061095a1675b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGTX","symbol_name":"Cognition Therapeutics, Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800061095a1675b&s=b","article_id":"2460736374","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800061095a1675b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2460736374","pubTimestamp":1723910633,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月18日，Cognition Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-7.04百万美元，同比减少48.84%；其中营业收入为0.00美元，每股基本收益为-0.18美元。机构评级：截至2024年8月18日，当前有6家机构对Cognition Therapeutics, Inc.目标价做出预测，其中目标均价为7.50美元，其中最低目标价为1.00美元，最高目标价为14.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"CGTX":"Cognition Therapeutics, Inc","LENZ":"Therapeutics"},"translate_title":"Cognition Therapeutics, Inc. achieved net profit of-US $7.04 million in the second fiscal quarter of fiscal 2024, a year-on-year decrease of 48.84%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGTX":1,"LENZ":1},"content_text":"8月18日，Cognition Therapeutics, Inc.（CGTX.US）公布财报，公告显示公司2024财年第二财季净利润为-7.04百万美元，同比减少48.84%；其中营业收入为0.00美元，每股基本收益为-0.18美元。从资产负债表来看，Cognition Therapeutics, Inc.（CGTX.US）总负债11.36百万美元，其中短期债务184000.00美元，资产负债比为3.03，流动比率为3.08。机构评级：截至2024年8月18日，当前有6家机构对Cognition Therapeutics, Inc.目标价做出预测，其中目标均价为7.50美元，其中最低目标价为1.00美元，最高目标价为14.00美元。公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。该公司的候选产品CT1812是一种口服小分子拮抗剂，旨在穿透血脑屏障并选择性地与S2R复合物结合。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460736374"}